1
|
Zhu JJ, Ai Y, Wu JH, Zeng CG, Cui Z, Zhang ZP, Zhu JY, Wang CQ, Zhong H. Ring-Contracted Artemisinin Derivatives as Novel CDK 4/6 Inhibitors: Synthesis and Anti-Breast Cancer Evaluation. Chem Biodivers 2024; 21:e202400086. [PMID: 38619074 DOI: 10.1002/cbdv.202400086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Revised: 04/13/2024] [Accepted: 04/15/2024] [Indexed: 04/16/2024]
Abstract
The endoperoxide group of artemisinins is universally accepted an essential group for their anti-cancer effects. In this study, a series of D-ring-contracted artemisinin derivatives were constructed by combining ring-contracted artemisinin core with fragments of functional heterocyclic molecules or classical CDK4/6 inhibitors to identify more efficacious breast cancer treatment agents. Twenty-six novel hybridized molecules were synthesized and characterized by HRMS, IR, 1H-NMR and 13C NMR. In antiproliferative activities and kinase inhibitory effects assays, we found that the antiproliferative effects of B01 were close to those of the positive control Palbociclib, with GI50 values of 4.87±0.23 μM and 9.97±1.44 μM towards T47D cells and MDA-MB-436 cells respectively. In addition, the results showed that B01 was the most potent compound against CDK6/cyclin D3 kinase, with an IC50 value of 0.135±0.041 μM, and its activity was approximately 1/3 of the positive control Palbociclib.
Collapse
Affiliation(s)
- Jun-Jie Zhu
- School of Pharmaceutical Sciences, Guizhou University, 550025, Guiyang, China
- Guizhou Engineering Laboratory for Synthetic Drugs, 550025, Guiyang, China
| | - Yi Ai
- School of Pharmaceutical Sciences, Guizhou University, 550025, Guiyang, China
- Guizhou Engineering Laboratory for Synthetic Drugs, 550025, Guiyang, China
| | - Jun-Hui Wu
- School of Pharmaceutical Sciences, Guizhou University, 550025, Guiyang, China
- Guizhou Engineering Laboratory for Synthetic Drugs, 550025, Guiyang, China
| | - Chang-Guang Zeng
- Technical Department of Criminal Investigation Branch, Deyang Police Office, 618000, Deyang, China
| | - Zhen Cui
- School of Pharmaceutical Sciences, Guizhou University, 550025, Guiyang, China
- Guizhou Engineering Laboratory for Synthetic Drugs, 550025, Guiyang, China
| | - Zheng-Ping Zhang
- School of Pharmaceutical Sciences, Guizhou University, 550025, Guiyang, China
- Guizhou Engineering Laboratory for Synthetic Drugs, 550025, Guiyang, China
| | - Jia-Yi Zhu
- School of Pharmaceutical Sciences, Guizhou University, 550025, Guiyang, China
- Guizhou Engineering Laboratory for Synthetic Drugs, 550025, Guiyang, China
| | - Chang-Qi Wang
- School of Pharmaceutical Sciences, Guizhou University, 550025, Guiyang, China
- Guizhou Engineering Laboratory for Synthetic Drugs, 550025, Guiyang, China
| | - Hang Zhong
- School of Pharmaceutical Sciences, Guizhou University, 550025, Guiyang, China
- Guizhou Engineering Laboratory for Synthetic Drugs, 550025, Guiyang, China
| |
Collapse
|
2
|
Verboni M, Olivieri D, Lucarini S. A recent update on new synthetic chiral compounds with antileishmanial activity. Chirality 2022; 34:1279-1297. [PMID: 35947400 PMCID: PMC9543214 DOI: 10.1002/chir.23494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 06/21/2022] [Accepted: 07/14/2022] [Indexed: 11/17/2022]
Abstract
Parasitic diseases, including malaria, leishmaniasis, and trypanosomiasis, affect billions of people and are responsible for almost 500,000 deaths/year. In particular, leishmaniasis, a neglected tropical disease, is considered a global public health problem because current drugs have several drawbacks including to toxicity, high cost, and drug resistance, which result in a lack of effective and readily available therapies. Therefore, the synthesis of new, safe, and effective molecules still requires the attention of the scientific community. Moreover, it is well known that chirality plays a crucial role in the antiparasitic activity of molecules, driving the design of their synthesis. Therefore, in this review we report a recent update on new chiral compounds with promising antileishmanial activity, focusing on synthetic approaches. Where reported, in most cases the enantiopure compound has shown better potency against the protozoa than its enantiomer or corresponding racemic mixture.
Collapse
Affiliation(s)
- Michele Verboni
- Department of Biomolecular Science, University of Urbino Carlo Bo, Urbino, Italy
| | - Diego Olivieri
- Department of Biomolecular Science, University of Urbino Carlo Bo, Urbino, Italy
| | - Simone Lucarini
- Department of Biomolecular Science, University of Urbino Carlo Bo, Urbino, Italy
| |
Collapse
|
3
|
Electrospun Nanofibers of Polycaprolactone/Collagen as a Sustained-Release Drug Delivery System for Artemisinin. Pharmaceutics 2021; 13:pharmaceutics13081228. [PMID: 34452189 PMCID: PMC8402154 DOI: 10.3390/pharmaceutics13081228] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2021] [Revised: 08/04/2021] [Accepted: 08/05/2021] [Indexed: 11/23/2022] Open
Abstract
The application of artemisinin (ART) in the treatment of malaria has been restricted to a certain degree due to its inherent limitations, such as short half-life, poor solubility, limited bioavailability, and re-crystallization. Electrospun nanofibers loaded with ART provide an excellent solution to these limitations and yield sustained drug release as well as inhibition of drug re-crystallization. In this study, ART-loaded polycaprolactone (PCL)/collagen (Col) nanofibers with different proportions of polymers were prepared. ART-loaded PCL/Col nanofibers were characterized, and further ART anti-crystallization and release behaviors were studied. SEM was used to observe the morphology of PCL/Col nanofibers. X-ray diffraction (XRD) was used to characterize the physical state of ART in ART-loaded PCL/Col nanofibers. Fourier transform infrared spectroscopy (FTIR), water contact angle measurement, weight loss, degree of swelling, and drug release experiments can verify the differences in performance of ART-loaded PCL/Col nanofibers due to different polymer ratios. The release curve was analyzed by kinetics, showing sustained release for up to 48 h, and followed the Fickian release mechanism, which was shown by the diffusion index value obtained from the Korsmeyer-Peppas equation.
Collapse
|
4
|
Semakov AV, Anikina LV, Klochkov SG. Synthesis and Cytotoxic Activity of the Products of Addition of Thiophenol to Sesquiterpene Lactones. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2021. [DOI: 10.1134/s106816202104018x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Abstract—
Derivatives of sesquiterpene lactones modified at the lactone ring with a thiophenol residue have been synthesized. The resulting conjugates with thiophenol have capacity for the oxidation–elimination reaction by the action of ROS of a tumor cell with the release of initial cytotoxic lactones. It has been proposed to use the resulting sulfur-containing conjugates as ROS-activated prodrugs of sesquiterpene lactones. The antiproliferative properties of the conjugates have been examined on tumor and pseudonormal cell lines. The cytotoxicity of the conjugates is lower than that of parent lactones; however, in some cases, as with the conjugates of alantolactone with artemisiten, it remains moderate in all tumor cell lines tested.
Collapse
|
5
|
Khongsti K, Pasupuleti BG, Das B, Bez G. 1,2,3-Triazole tethered 1,2,4‑trioxane trimer induces apoptosis in metastatic cancer cells and inhibits their proliferation, migration and invasion. Bioorg Chem 2021; 112:104952. [PMID: 33971565 DOI: 10.1016/j.bioorg.2021.104952] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2020] [Revised: 04/20/2021] [Accepted: 04/24/2021] [Indexed: 12/24/2022]
Abstract
Artemisinin (ART) has been in use against different cancer cells and its derivatives and conjugates are more cytotoxic to iron-rich cancer cells. It is desirable to develop easily achievable synthetic 1,2,4-trioxanes having the same pharmacophore as that of ART. To explore more efficient compounds, a 1,2,3-triazole tethered 1,2,4‑trioxane trimer (4T) was synthesized and the anti-cancer effects of ART and 4T on MDA-MB-435 and MDA-MB-231 cells were investigated concerning regulation of osteopontin (OPN) expression, which is associated with cancer progression and malignancy. 1H NMR and 13C NMR, oxidative stress analysis, flow cytometry, western blot, Real-Time PCR, transfections, luciferase assay, cell viability, proliferation, migration and chemotactic invasion assays were used in this study. It was observed that the 4T induced apoptosis by inhibiting Bcl-2 (~0.6-fold) and cleavage of caspase-3 (intrinsic pathway) in these metastatic cancer cells, and also reduced colony formation, migration and invasion of these cancer cells. The treatment of 4T decreased the reduced glutathione level and increased the activities of glucose-6-phosphate dehydrogenase and glutathione reductase in the 4T treated cancer cells as compared to their respective controls. Further, the expression of OPN was diminished (~0.5-fold) by the 4T in these cell lines. It was also observed that the key mitogen-activated protein kinase pathway proteins, mitogen-activated protein kinase kinase1/2 (~1.8-fold) and extracellular signal-regulated kinase1/2 (~16-fold), were also activated following the treatment of the 4T. However, the phosphorylated c-Jun level, a component of activator protein-1, was significantly reduced in these cancer cells upon 4T treatment. Taken together, we hypothesize that 4T may be useful for controlling cancer progression and malignancy.
Collapse
Affiliation(s)
- Kitboklang Khongsti
- Department of Zoology, North-Eastern Hill University, Shillong 793022, India
| | | | - Bidyadhar Das
- Department of Zoology, North-Eastern Hill University, Shillong 793022, India.
| | - Ghanashyam Bez
- Department of Chemistry, North-Eastern Hill University, Shillong 793022, India.
| |
Collapse
|
6
|
In vitro efficacy of synthesized artemisinin derivatives against Leishmania promastigotes. Bioorg Med Chem Lett 2020; 30:127581. [DOI: 10.1016/j.bmcl.2020.127581] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2020] [Revised: 09/18/2020] [Accepted: 09/22/2020] [Indexed: 01/22/2023]
|
7
|
Veale CGL, Müller R. Recent Highlights in Anti-infective Medicinal Chemistry from South Africa. ChemMedChem 2020; 15:809-826. [PMID: 32149446 DOI: 10.1002/cmdc.202000086] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Indexed: 12/17/2022]
Abstract
Global advancements in biological technologies have vastly increased the variety of and accessibility to bioassay platforms, while simultaneously improving our understanding of druggable chemical space. In the South African context, this has resulted in a rapid expansion in the number of medicinal chemistry programmes currently operating, particularly on university campuses. Furthermore, the modern medicinal chemist has the advantage of being able to incorporate data from numerous related disciplines into the medicinal chemistry process, allowing for informed molecular design to play a far greater role than previously possible. Accordingly, this review focusses on recent highlights in drug-discovery programmes, in which South African medicinal chemistry groups have played a substantive role in the design and optimisation of biologically active compounds which contribute to the search for promising agents for infectious disease.
Collapse
Affiliation(s)
- Clinton G L Veale
- School of Chemistry and Physics, Pietermaritzburg Campus, University of KwaZulu-Natal, Private Bag X01, Scottsville, 3209, South Africa
| | - Ronel Müller
- School of Chemistry and Physics, Pietermaritzburg Campus, University of KwaZulu-Natal, Private Bag X01, Scottsville, 3209, South Africa
| |
Collapse
|
8
|
Xia M, Liu D, Liu Y, Liu H. The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease. Front Pharmacol 2020; 11:380. [PMID: 32296335 PMCID: PMC7136752 DOI: 10.3389/fphar.2020.00380] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2019] [Accepted: 03/12/2020] [Indexed: 12/12/2022] Open
Abstract
Artemisinin (ARS) and its derivatives (ARSs) are recommended as the first-line antimalarial drugs for the treatment of malaria. Besides antimalarial function, its potent anti-inflammatory and immunoregulatory properties, as well as the ability to regulate oxidative stress have brought them to a prominent position. As researchers around the world are continually exploring the unknown biological activities of ARS derivatives, experimental studies have shown much progress in renal therapy. This review aims to give a brief overview of the current research on ARSs applications for kidney treatment with the evaluation of therapeutic properties and potential molecular mechanisms.
Collapse
Affiliation(s)
- Ming Xia
- Department of Nephrology, The Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, China
| | - Di Liu
- Department of Nephrology, The Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, China
| | - Yu Liu
- Department of Nephrology, The Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, China
| | - Hong Liu
- Department of Nephrology, The Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, China
| |
Collapse
|
9
|
Botta L, Filippi S, Bizzarri BM, Zippilli C, Meschini R, Pogni R, Baratto MC, Villanova L, Saladino R. Synthesis and Evaluation of Artemisinin-Based Hybrid and Dimer Derivatives as Antimelanoma Agents. ACS OMEGA 2020; 5:243-251. [PMID: 31956771 PMCID: PMC6964273 DOI: 10.1021/acsomega.9b02600] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/13/2019] [Accepted: 10/15/2019] [Indexed: 05/05/2023]
Abstract
A library of hybrid and dimer compounds based on the natural scaffold of artemisinin was synthesized. These derivatives were obtained by coupling of artemisinin derivatives, artesunate, and dihydroartemisinin with a panel of phytochemical compounds. The novel artemisinin-based hybrids and dimers were evaluated for their anticancer activity on a cervical cancer cell line (HeLa) and on three complementary metastatic melanoma cancer cell lines (SK-MEL3, SK-MEL24, and RPMI-7951). Two hybrid compounds obtained by coupling of artesunate with eugenol and tyrosol, and one of the dimer compounds containing curcumin, emerged as the most active and cancer-selective derivatives.
Collapse
Affiliation(s)
- Lorenzo Botta
- Department
of Ecological and Biological Sciences, University
of Tuscia, via S. C. De Lellis 44, 01100, Viterbo, Italy
- E-mail: (L.B.)
| | - Silvia Filippi
- Department
of Ecological and Biological Sciences, University
of Tuscia, via S. C. De Lellis 44, 01100, Viterbo, Italy
| | - Bruno M. Bizzarri
- Department
of Ecological and Biological Sciences, University
of Tuscia, via S. C. De Lellis 44, 01100, Viterbo, Italy
| | - Claudio Zippilli
- Department
of Ecological and Biological Sciences, University
of Tuscia, via S. C. De Lellis 44, 01100, Viterbo, Italy
| | - Roberta Meschini
- Department
of Ecological and Biological Sciences, University
of Tuscia, via S. C. De Lellis 44, 01100, Viterbo, Italy
| | - Rebecca Pogni
- Department
of Biotechnology, Chemistry and Pharmacy, University of Siena, via Aldo Moro 2, 53100 Siena, Italy
| | - Maria Camilla Baratto
- Department
of Biotechnology, Chemistry and Pharmacy, University of Siena, via Aldo Moro 2, 53100 Siena, Italy
| | - Luciano Villanova
- Lachifarma
s.r.l., S.S.16 Zona Industriale, 73010, Zollino, Lecce, Italy
| | - Raffaele Saladino
- Department
of Ecological and Biological Sciences, University
of Tuscia, via S. C. De Lellis 44, 01100, Viterbo, Italy
- E-mail: (R.S.)
| |
Collapse
|
10
|
Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma. Semin Cancer Biol 2019; 59:266-282. [PMID: 31233829 DOI: 10.1016/j.semcancer.2019.06.011] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2019] [Revised: 06/19/2019] [Accepted: 06/21/2019] [Indexed: 12/12/2022]
Abstract
Melanoma is the most fatal form of skin cancer. Current therapeutic approaches include surgical resection, chemotherapy, targeted therapy and immunotherapy. However, these treatment strategies are associated with development of drug resistance and severe side effects. In recent years, natural compounds have also been extensively studied for their anti-melanoma effects, including tumor growth inhibition, apoptosis induction, angiogenesis and metastasis suppression and cancer stem cell elimination. Moreover, a considerable number of studies reported the synergistic activity of phytochemicals and standard anti-melanoma agents, as well as the enhanced effectiveness of their synthetic derivatives and novel formulations. However, clinical data confirming these promising effects in patients are still scanty. This review emphasizes the anti-tumor mechanisms and potential application of the most studied natural products for melanoma prevention and treatment.
Collapse
|
11
|
Nyein CM, Zhong X, Lu J, Luo H, Wang J, Rapposelli S, Li M, Ou-Yang Y, Pi R, He X. Synthesis and anti-glioblastoma effects of artemisinin-isothiocyanate derivatives. RSC Adv 2018; 8:40974-40983. [PMID: 35557894 PMCID: PMC9091658 DOI: 10.1039/c8ra08162j] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2018] [Accepted: 11/19/2018] [Indexed: 11/29/2022] Open
Abstract
A series of novel artemisinin (ART) derivatives containing an isothiocyanate (ITC) group were synthesized. All the compounds showed more potent anti-tumor effects than those of parent dihydroartemisinin (DHA) towards glioblastoma multiforme U87 in vitro. Among them, 5b had the strongest cytotoxic activity which exerted its effects in a concentration-dependent but not time-dependent manner (IC50 7.41 μM for 24 h, 7.35 μM for 72 h). Pyknosis was observed in 5b-treated U87 cells. Multiple intrinsic apoptotic pathways were induced by 5b including the upregulation of caspase 9, the release of cytochrome c, an increase of the proapoptotic protein Bax, a decrease of the anti-apoptotic protein Bcl 2, and the activation of execution pathways by the upregulation of caspase 3. In addition to apoptosis, an autophagic mechanism was also involved in 5b-induced cytotoxicity to human GBM U87 cells by upregulating the expression of LC3-II and downregulating p62. Furthermore, 5b also significantly attenuated the migration of U87 cells. Therefore, our results suggest that 5b may be a promising molecule for the further development of a novel drug for the treatment of glioblastoma. Synthesis of artemisinin-isothiocyanate derivatives; evaluation of the cytotoxic effects of these compounds on U87 human glioblastoma cells; compound 5b induced apoptosis and autophagy in U87 cells; compound 5b significantly inhibited the migration of U87 cells.![]()
Collapse
Affiliation(s)
- Chan Myae Nyein
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine Guangzhou 510006 China .,School of Pharmaceutical Sciences, Sun Yat-Sen University Guangzhou 510006 China .,Biotechnology Research Department, Ministry of Education Kyauk-se Myanmar
| | - Xiaolin Zhong
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine Guangzhou 510006 China
| | - Junfeng Lu
- School of Pharmaceutical Sciences, Sun Yat-Sen University Guangzhou 510006 China
| | - Huijuan Luo
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine Guangzhou 510006 China
| | - Jiamin Wang
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine Guangzhou 510006 China
| | - Simona Rapposelli
- Department of Pharmacy, University of Pisa Via Bonanno, 6 56126 Pisa Italy.,Interdepartmental Research Center for Biology and Pathology of Aging, University of Pisa Via Bonanno, 6 56126 Pisa Italy
| | - Mingtao Li
- Guangdong Provincial Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-Sen University Guangzhou China
| | - Ying Ou-Yang
- Department of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou 510120 China
| | - Rongbiao Pi
- School of Pharmaceutical Sciences, Sun Yat-Sen University Guangzhou 510006 China .,Guangdong Provincial Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-Sen University Guangzhou China
| | - Xixin He
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine Guangzhou 510006 China
| |
Collapse
|
12
|
Liu X, Zhang Y, Huang W, Luo J, Li Y, Tan W, Zhang A. Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin. Eur J Med Chem 2018; 159:149-165. [PMID: 30278333 DOI: 10.1016/j.ejmech.2018.09.059] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2018] [Revised: 09/23/2018] [Accepted: 09/24/2018] [Indexed: 11/24/2022]
Abstract
By taking advantage of the apoptosis-inducing capacity of artemisinin derivatives, we developed several series of compounds by merging the basic structural elements of the natural product artemisinin into the P2 interaction pocket of the clinically prescribed Bcl-2 inhibitor venetoclax. Most of the new compounds displayed improved biochemical potency against Bcl-2 and high selectivity over Bcl-xL. Specifically, compounds 27c and 34c were found to be the most potent with IC50 values less than 2.0 nM. Unfortunately, these compounds only showed moderate antiproliferative effects against Bcl-2 dependent cells. Though further structural optimization is needed to improve the cellular absorptive permeability, the current approach represents an alternative strategy to develop novel Bcl-2 inhibitors with greater selectivity over Bcl-xL, which is related to the off-target adverse effects of venetoclax.
Collapse
Affiliation(s)
- Xiaohua Liu
- CAS Key Laboratory of Receptor Research, The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, 201203, China
| | - Yu Zhang
- Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China
| | - Wenjing Huang
- Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China
| | - Jia Luo
- Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China
| | - Yang Li
- CAS Key Laboratory of Receptor Research, The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, 201203, China
| | - Wenfu Tan
- Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China.
| | - Ao Zhang
- CAS Key Laboratory of Receptor Research, The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, 201203, China; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
| |
Collapse
|
13
|
Lam NS, Long X, Su XZ, Lu F. Artemisinin and its derivatives in treating helminthic infections beyond schistosomiasis. Pharmacol Res 2018; 133:77-100. [DOI: 10.1016/j.phrs.2018.04.025] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/21/2017] [Revised: 04/12/2018] [Accepted: 04/30/2018] [Indexed: 12/26/2022]
|
14
|
Kumari K, Keshari S, Sengupta D, Sabat SC, Mishra SK. Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment. BMC Cancer 2017; 17:858. [PMID: 29246124 PMCID: PMC5732364 DOI: 10.1186/s12885-017-3863-7] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2017] [Accepted: 11/23/2017] [Indexed: 12/13/2022] Open
Abstract
Background Well-known anti-malarial drug artemisinin exhibits potent anti-cancerous activities. In-vivo and in-vitro studies showed its anti-tumor and immunomodulatory properties signifying it as a potent drug candidate for study. The studies of mechanisms of cell movement are relevant which can be understood by knowing the involvement of genes in an effect of a drug. Although cytotoxicity and anti-proliferative activity of artemisinin is evident, the genes participating in its anti-migratory and reduced invasive effect are not well studied. The present study reports the alteration in the expression of 84 genes involved in cell motility upon artemisinin treatment in MCF-7 breast cancer cells using pathway focused gene expression PCR array. In addition, the effect of artemisinin on epigenetic modifier HDACs is studied. Methods We checked the functional stimulus of artemisinin on cell viability, migration, invasion and apoptosis in breast cancerous cell lines. Using qRT-PCR and western blot, we validated the altered expression of relevant genes associated with proliferation, migration, invasion, apoptosis and mammary gland development. Results Artemisinin inhibited cell proliferation of estrogen receptor negative breast cancer cells with fewer efficacies in comparison to estrogen receptor positive ones. At the same time, cell viability and proliferation of normal breast epithelial MCF10A cells was un-affected. Artemisinin strongly inhibited cancer cell migration and invasion. Along with orphan nuclear receptors (ERRα, ERRβ and ERRγ), artemisinin altered the ERα/ERβ/PR/Her expression status of MCF-7 cells. The expression of genes involved in the signaling pathways associated with proliferation, migration, invasion and apoptosis was significantly altered which cooperatively resulted into reduced growth promoting activities of breast cancer cells. Interestingly, artemisinin exhibited inhibitory effect on histone deacetylases (HDACs). Conclusions Upregulated expression of tumor suppressor genes along with reduced expression of oncogenes significantly associated with growth stimulating signaling pathways in response to artemisinin treatment suggests its efficacy as an effective drug in breast cancer treatment.
Collapse
Affiliation(s)
- Kanchan Kumari
- Cancer Biology Laboratory, Institute of Life Sciences (Government of India), Nalco Square, Bhubaneswar, Odisha, 751023, India
| | | | | | - Surendra C Sabat
- Molecular biology of abiotic stress, Institute of Life Sciences, Nalco Square, Bhubaneswar, Odisha, 751023, India
| | - Sandip K Mishra
- Cancer Biology Laboratory, Institute of Life Sciences (Government of India), Nalco Square, Bhubaneswar, Odisha, 751023, India.
| |
Collapse
|
15
|
Kholiya R, Khan SI, Bahuguna A, Tripathi M, Rawat DS. N-Piperonyl substitution on aminoquinoline-pyrimidine hybrids: Effect on the antiplasmodial potency. Eur J Med Chem 2017; 131:126-140. [PMID: 28315598 DOI: 10.1016/j.ejmech.2017.03.007] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2016] [Revised: 03/02/2017] [Accepted: 03/03/2017] [Indexed: 11/29/2022]
Abstract
A series of 4-aminoquinoline-piperonyl-pyrimidine hybrids were synthesized with the aim of identifying compounds with enhanced antimalarial activity. All the synthesized molecules were evaluated in vitro against cultured Plasmodium falciparum W2 and D6 strains and exhibited potent antiplasmodial activities with IC50 values in the range of 0.02-5.16 μM. Out of the 22 synthesised hybrids, 12 were found to be better (up to eight-fold more active) than chloroquine (CQ), particularly against the CQ-resistant W2 strain of P. falciparum with no significant cytotoxicity towards the mammalian cells. Mechanistic studies reveal that these compounds bind with heme and computational docking studies showed good docking interactions within the active site of Pf-DHFR.
Collapse
Affiliation(s)
- Rohit Kholiya
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Shabana I Khan
- National Centre for Natural Products Research, University of Mississippi, MS 38677, USA
| | - Aparna Bahuguna
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Mohit Tripathi
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Diwan S Rawat
- Department of Chemistry, University of Delhi, Delhi 110007, India.
| |
Collapse
|